- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fischer's Q2 revenues climb 21%
Fischer Imaging saw revenues jump 21% for its second quarter (end-June)due to continued success in selling systems through its OEM partners.The Denver company also saw net income more than double in theperiod. For the quarter, Fischer reported sales of
Fischer Imaging saw revenues jump 21% for its second quarter (end-June)due to continued success in selling systems through its OEM partners.The Denver company also saw net income more than double in theperiod.
For the quarter, Fischer reported sales of $21.9 million, upsharply from the $18.1 million posted in the second quarter of1995. Net income stood at $946,000, compared with $397,000 inthe same period the year before.
Fischer chairman and CEO Morgan Nields reported that Fischer'sSenoScan full-field digital mammography program is moving forward:Fischer is planning to ship its second clinical trial unit inthe next several weeks, with clinical trials to follow. Fischerplans to submit a regulatory application for the system in thesecond half of this year, with clearance expected in 1997.
Fischer earlier this month completed a secondary stock offeringthat raised $13.5 million. The company is now virtually debt-freeand has cash on hand to fund growth opportunities, according toCFO Jim Newcomb.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
